Apnea of Prematurity | CHOP Research Institute
 

Apnea of Prematurity

Eric C. Eichenwald, MD
Eric C. Eichenwald

Dr. Eichenwald's research interests include clinical trials and quality improvement in neonatal-perinatal medicine. He has extensive experience in the conduct of multicenter clinical trials, having served as a site principal investigator for several funded, multicenter randomized trials of interventions aimed at improving outcomes of premature newborns.

E-mail:
eichenwald [at] chop.edu

Do the Effects of Neonatal Caffeine Therapy Persist in Middle School?

Published on
May 23, 2017
in Cornerstone Blog
Neonatal Caffeine Therapy
Caffeine therapy can help premature babies breathe stronger and sooner on their own. When a group of caffeine-treated premature babies reached middle school, the therapy appeared to reduce their risk of motor impairment – building on earlier follow-ups that show the treatment's safety, efficacy, and developmental benefits for the babies at one-and-a-half years old.